Evidence map›Paper›PMID 34914066›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2022

A Fast-Track Phenotypic Characterization of Plasmodium falciparum Vaccine Antigens through Lyse-Reseal Erythrocytes Mediated Delivery (LyRED) of RNA Interference for Targeted Translational Repression.

Malabika Chakrabarti, Swati Garg, Akshay Munjal, Sweta Karan, Soumya Pati, Lalit C Garg, Shailja Singh

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Host-parasite interactions duringFrontiers in immunology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Malabika ChakrabartiSpecial Centre for Molecular Medicine, Jawaharlal Nehru University, New Delhi, India.
Swati GargSpecial Centre for Molecular Medicine, Jawaharlal Nehru University, New Delhi, India.
Akshay MunjalSpecial Centre for Molecular Medicine, Jawaharlal Nehru University, New Delhi, India.
Sweta KaranGene Regulation Laboratory, National Institute of Immunology, New Delhi, India.
Soumya PatiDepartment of Life Science, School of Natural Sciences, Shiv Nadar University, Gautam Buddh Nagar, Uttar Pradesh, India.
Lalit C GargGene Regulation Laboratory, National Institute of Immunology, New Delhi, India. lalit@nii.ac.in.
Shailja SinghSpecial Centre for Molecular Medicine, Jawaharlal Nehru University, New Delhi, India. shailjasingh@mail.jnu.ac.in.
Jawaharlal Nehru University · INNational Institute of Immunology · INShiv Nadar University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The minimal success of the malaria vaccine with available antigens indicates the need for intensive and accelerated research to identify and characterize new antigens that confer protection against infection, clinical manifestation, and even malaria transmission. Further, the genetic manipulation tools to characterize such antigens are very time-consuming and laborious due to the very low efficiency of transfection in the malaria parasite. Here, we report a human miRNA-mediated translational repression of antigens in Plasmodium falciparum as a fast-track method for understanding and validating their function. In this method, candidate miRNAs are designed based on favorable hybridization energy against a parasite gene, and miRNA mimics are delivered to the parasite by loading them as cargo in the erythrocytes by simple lyse-reseal method. Incubation of the miRNA loaded erythrocytes with purified mature trophozoites or schizonts results in the loaded erythrocytes' infection. The miRNA mimics are translocated to parasites, and the effect of miRNA-mediated translation repression can be monitored within 48-72 h post-invasion. Unlike other transfection based methods, this method is fast, reproducible, and robust. We call this method as lyse-reseal erythrocytes for delivery (LyRED) of miRNA, which is a rapid and straight-forward method providing an efficient alternative to the existing genetic tools for P. falciparum to characterize the function of antigens or genes. The identification of crucial antigens from the different stages of the Plasmodium falciparum life cycle by the miRNA targeting approach can fuel the development of efficacious subunit vaccines against malaria.

Indexed as

Malaria, FalciparumMalaria VaccinesPlasmodium falciparumAnimalsAntigens, ProtozoanErythrocytesHumansMicroRNAsProtozoan ProteinsRNA InterferenceAntigens, ProtozoanMalaria VaccinesMicroRNAsProtozoan ProteinsAntigenLyse-reseal erythrocytesmicro-RNAPfApicortinPlasmodiumTranslational repressionVaccine

Identifiers

PMID34914066
OpenAlexW4200044791

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.